Chemical Structure (Mannitol 01)
Mannitol Injection, Solution
Product Images NDC 0409-4031
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mannitol (NDC 0409-4031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Mannitol 02)
Principal Display Panel (50 mL Vial Label)
This is a description of a single-dose Fliptop vial available only through prescription, with an NDC code of 0409-4031-16. It contains 250 mg Mannitol per mL and may also contain sodium bicarbonate and/or HCl. The injection must be inspected carefully, should be administered intravenously at a temperature of 30° to 377 (86° to 98.6°F), and must be filtered through a sterile filter. The usual dosage should be seen in the insert. The injection is nonpyrogenic and is intended for intravenous use. It must be stored at room temperature, and protected from freezing, and should only be used if the seal is intact. Severe renal impairment is a contraindication, as mentioned in the insert. The injection is distributed by Hospira, Inc, in Lake Forest, Illinois, USA. However, the last word "Hospr" seems to be not-readable, so it may not be accurate.*
Principal Display Panel (50 mL Vial Tray)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
